Sobi has once again been recognised for its commitment to sustainability and responsible business practices, earning a place in the Dow Jones Best-in-Class (DJ BIC) Indices.
For the fourth consecutive year, Sobi is included in the DJ BIC Europe Index, and for the first time, is also part of the DJ BIC World Index. This is a significant milestone that reflects our growing global impact and continued progress in sustainability.
“This recognition reflects our continued efforts to integrate sustainability throughout our organisation and advance it across the entire value chain. Thank you to everyone at Sobi who makes sustainability part of how we work every day,” says Cecilia Nord, Global Head of Sustainability.
The Dow Jones Best in Class (DJ BIC) Indices evaluate companies based on their environmental, social, and governance (ESG) performance.
Companies included in the indices are recognised as leaders within their industries, based on a comprehensive assessment covering areas such as:
Being included in the DJ BIC means that Sobi ranks among the top performers in our sector, demonstrating strong integration of sustainability into our business strategy and transparent reporting on our progress.
Learn more about sustainability at Sobi in the 2025 Annual and sustainability report.
We are a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases.
Our therapies are concentrated within the areas of Haematology, Immunology and Specialty Care.
We contribute to societies by improving access to treatment of rare diseases.
Here we present our most recent press releases, stories, news articles, and images.
Find out more about our business and financial performance.
Every day, we work actively to find better ways to understand and meet patient needs.